ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jun 4, 2013
Evaluating the Industry Structure of Managed Care Organizations
We take a look at the managed care organization (MCO) and health insurance/benefits industry. We're comfortable being on the sidelines.
Jun 4, 2013
ASCO Reveals That Big Pharma Is Alive
Some good news from Bristol-Myers Squibb, Merck, GlaxoSmithKline, and Amgen showed the promise of immunotherapies for cancer treatment.
Jun 3, 2013
Revisiting the Real Risks of Linn Energy
To some, Linn Energy is a high-yielding savior; to others, it’s a Ponzi scheme. Let’s take a look at the controversial name.
Jun 1, 2013
Market Swoons in Late Trading Friday
Valuentum members were well-positioned in advance of the recent market slide. Large cap technology offers the best valuation support, in our view.
May 30, 2013
M&A Boom?
We take a look at some potential acquisition targets.
May 30, 2013
Astronics Acquires Peco to Get Closer to Boeing
Best Ideas Newsletter holding Astronics acquired Peco for $136 million.
May 30, 2013
Two Huge Deals as M&A Accelerates
Smithfield sells itself and Valeant makes another splash in M&A.
May 29, 2013
The Impact of the US Housing Recovery Cannot Be Underestimated
Valuentum reveals the far-reaching implications of a strengthening US housing market.
May 29, 2013
Tiffany Leaps A Low Hurdle
Tiffany set itself up earlier in the quarter to easily exceed estimates by tempering expectations.
May 26, 2013
The Mortgage REIT Business Doesn't Work...
...if interest rates go up and if the yield curve is flatter. - Gary Kain, President and CIO, American Capital Agency (AGNC), May 23, 2013, acknowledging the "very real" bear case.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.